Brought to you by:
VIVA 2021: IVL ‘consistently’ treats real-world calcium in multiple peripheral vessel beds
An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL) performs “consistently well” across challenging peripheral vessels, lesions and subgroups of patients, Ehrin J. Armstrong, MD, medical director at Adventist Heart and Vascular Institute in…
Vascular surgeons found to ask twice as many closed- versus open-ended questions in patient encounters
Patients reported they mostly felt their provider was adequate in terms of engaging in shared decision-making during asymptomatic vascular consults, according to a qualitative analysis carried out at the University of Iowa in Iowa City. Furthermore, vascular surgery compared favorably…
Study detects no difference in adverse outcomes from balloon dilatation strategy used during TCAR
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularization (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery stenting, new research has shown. Jones Thomas, MD, an integrated vascular surgery resident at University Hospitals…
Two-year Ranger DCB data demonstrate ‘sustained, high rate’ of device efficacy
Patients treated with Boston Scientific’s Ranger drug-coated balloon (DCB) sustained “improved primary patency” with fewer reinterventions than those treated with uncoated devices, two-year results from the RANGER II SFA randomized controlled trial have demonstrated, investigators revealed during a late-breaking session…
VIVA 2021: IN.PACT Admiral DCB found to provide ‘high five-year freedom from clinically driven TLR’ in patients with complex lesions
Real-world data drawn from the IN.PACT Global study looking at five-year freedom from clinically driven target lesion revascularization (TLR) among prespecified chronic total occlusion (CTO), long lesion and de novo in-stent restenosis (ISR) cohorts “continues to confirm long-term clinical safety…
VIVA 2021: Consensus established for appropriate use of IVUS in peripheral interventions
A worldwide committee of 40 cross-specialty medical experts achieved what was hailed as the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions. Global experts conducted a systematic and comprehensive review of key…
Cuts to Medicare: ‘As vascular disease complexity increases, reimbursement for complex care decreases’
Outgoing Midwestern Vascular Surgical Society (MVSS) President Kellie Brown, MD, has seen fundamental changes to the way vascular surgery is practiced during her 20 years as a surgeon. The advance of endovascular techniques. The arrival of the electronic medical record…
AI and transforming vascular surgery
The 2021 Vascular Annual Meeting (VAM) Roy Greenberg Distinguished Lecture saw delegates hear about the potential for artificial intelligence (AI) to transform vascular surgery. Elsie Gyang Ross, MD, assistant professor of surgery at Stanford University, told attendees during her Aug.…
Surgeons relate patient-reported outcomes experiences
Ashley K. Vavra, MD, and Christopher J. Smolock, MD, talk to Vascular Specialist about why they decided to collect patient-reported outcomes (PROs), how they got started with them and the challenges they have faced. Vavra is a member and Smolock…
VQI partners with Symmetric Health Solutions to improve device identification accuracy
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has announced a partnership with Symmetric Health Solutions aimed at elevating the consistency and integrity of medical device data utilized by vascular health professionals. The link-up with the healthcare supply…